Table 2. Chlamydia infection in the 3MOMP vaccine cohort.
| 3MOMP Vaccine | ||||||
|---|---|---|---|---|---|---|
| Ocular Loads | UGT Loads | Chlamydiosis during the 6-month trial | Chlamydiosis post the 6-month trial | |||
| Months post-vaccine | Months post-vaccine | |||||
| 0 | 6 | 0 | 6 | |||
| M1 | BDL | BDL | BDL | BDL | N | Y |
| M2 | 224 | BDL | BDL | BDL | N | N |
| M3 | BDL | BDL | BDL | BDL | N | N |
| M4 | BDL | BDL | BDL | BDL | N | N |
| M5 | BDL | BDL | BDL | BDL | N | N |
| M6 | BDL | BDL | BDL | BDL | N | N |
| M7 | BDL | BDL | BDL | BDL | N | N |
| M8 | BDL | BDL | 337 | 278 | N | N |
| M9 | BDL | BDL | BDL | BDL | N | N |
| M10 | BDL | BDL | 228 | BDL | N | N |
| M11 | 590 | BDL | 186 | BDL | N | N |
| M12 | BDL | BDL | BDL | BDL | N | Y |
| M13 | BDL | BDL | BDL | BDL | N | N |
| M14 | 219 | BDL | 284 | BDL | N | N |
| M15 | BDL | BDL | BDL | BDL | N | N |
| M16 | BDL | BDL | BDL | BDL | N | N |
| M17 | 193 | BDL | BDL | BDL | N | N |
| M18 | BDL | BDL | BDL | BDL | N | Y |
| M19 | BDL | BDL | BDL | BDL | N | N |
| M20 | BDL | BDL | BDL | BDL | N | N |
| M21 | BDL | BDL | BDL | BDL | N | N |
Infection with C. pecorum was assessed in the 3MOMP vaccine cohort using our C. pecorum 16S qPCR assay. Loads obtained are indicated for each koala in copies/μL of sample, pre and post-vaccination. BDL stands for Below Detection Level, and corresponds to <100 copies/ μL. Clinical disease status were recorded for each koala whether it occurred during the trial or during the 3 months past the trial period.